An animal comparison of long-term immune responses and protection from Omicron XBB.1.5 after different mRNA and MVA vaccine schedules and boosters.
Key Takeaways
- Although mRNA-based COVID-19 vaccines have demonstrated high efficacy
- Mice received by intramuscular route homologous (mRNA/mRNA and MVA/MVA)
- Whereas neutralizing antibody titers peaked early after the last vaccination and progressively declined